Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…

Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.

Hypernatraemia

Endocrinology and metabolism · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull
!
Escalate

Hypernatraemia with shock, severe dehydration, reduced consciousness, seizure or rapidly evolving neurological signs is a medical emergency. Resuscitate compromised circulation first, measure sodium repeatedly during water replacement and involve critical care, renal or endocrine specialists. Known arginine vasopressin deficiency with omitted desmopressin requires immediate medicines reconciliation, but fluid replacement takes priority in a seriously unwell depleted patient.

Synopsis

Restore circulation and free water safely, identify impaired access or renal water loss, and prevent dangerous over-rapid tonicity change.

  • Hypernatraemia usually means water deficit relative to body sodium, caused by inadequate access or thirst, extrarenal water loss, osmotic diuresis or arginine vasopressin deficiency or resistance.
  • Older, cognitively impaired, intubated, postoperative and care-dependent adults are vulnerable because they cannot obtain water even when renal physiology and thirst would otherwise protect them.
  • Assess circulation before calculating free water: shock requires isotonic resuscitation first. In decompensated AVP deficiency with persistent excessive dilute urine, Society guidance advises desmopressin 1–2 micrograms IV or IM and serum sodium every 4 hours during resuscitation.
  • Prefer oral or nasogastric water as soon as safe; select intravenous water-equivalent fluid and rate from sodium trajectory, glucose, losses, volume status and local specialist guidance.
  • Measure urine volume and osmolality: in hypernatraemia, a kidney that cannot concentrate urine suggests renal water loss from AVP deficiency, AVP resistance or osmotic diuresis.
  • Desmopressin is life-sustaining in central AVP deficiency, and omission or delay has caused severe dehydration and death according to the NHS England safety alert.
  • Once desmopressin controls a high urine output, ongoing free-water prescription can lower sodium unexpectedly quickly; coordinate the medicine and fluid rather than managing them independently.
  • Correction rate depends on duration and symptoms; presumed chronic or unknown-duration disease requires a conservative specialist-agreed trajectory with frequent adjustment, not a one-off deficit calculation.

Key red flags

Cerebral dehydration

Lethargy, irritability, confusion, hyperreflexia, weakness, seizure or coma suggests clinically important hypertonicity and requires urgent neurological and biochemical assessment.

Circulatory depletion

Tachycardia, hypotension, poor peripheral perfusion, dry mucosa and oliguria indicate priority restoration of intravascular volume before free-water calculation dominates care.

Polyuric AVP disorder

Large volumes of pale urine, intense thirst, pituitary disease, neurosurgery or missed desmopressin raises central AVP deficiency and must trigger immediate endocrine review.

Iatrogenic sodium gain

Hypertonic saline, sodium bicarbonate, concentrated enteral feed without water or dialysis error can raise sodium rapidly and needs immediate source control and specialist correction.

Investigation priorities

01
Serial serum sodium and measured osmolalityFirst step

Confirm hypertonicity and quantify the actual response to fluid and desmopressin treatment.

Management branches

ResuscitateRestore effective circulation first

The hypernatraemic adult has shock, hypotension or clinically important hypovolaemia.

  1. Use ABCDE, obtain urgent serum and urine studies, secure accurate input and output measurement and identify ongoing gastrointestinal, renal, skin or iatrogenic losses.
  2. Give isotonic crystalloid resuscitation according to NICE CG174 and repeated haemodynamic assessment despite the raised sodium, because organ perfusion takes immediate priority.
  3. Once circulation is restored, calculate an initial water plan and move to oral, nasogastric or appropriate intravenous free-water replacement with a documented sodium trajectory.
ReplaceCorrect water deficit iteratively

Haemodynamics are stable but hypertonicity and a water deficit remain.

  1. Estimate duration, deficit and ongoing losses, then choose the safest enteral or intravenous route considering swallow, glucose, renal function, heart failure and access.
  2. Set an explicit conservative target for chronic or uncertain-duration hypernatraemia with renal or endocrine advice, prescribing only the next review interval rather than the entire estimated deficit blindly.
  3. Remeasure sodium and fluid balance frequently, increasing, reducing or pausing water according to the observed slope and neurological and respiratory examination.

Key medicines

Desmopressin for central AVP deficiencyContinue the person's verified stable formulation and dose when safe. In decompensated AVP deficiency, restore fluid first; if excessive dilute urine persists, give desmopressin 1–2 micrograms IV or IM, with serum sodium every 4 hours during resuscitation and response review before any repeat dose.Fluid resuscitation takes priority in shock. Monitor sodium, urine output and intake closely because antidiuresis can convert an active water prescription into rapid correction or hyponatraemia; check renal and cardiac cautions and never guess a route conversion.
Enteral water or intravenous glucose 5%Prescribe the calculated but frequently revised free-water amount over the next monitored interval, preferring oral or nasogastric delivery when safe and using glucose 5% intravenously only within local fluid governance.Account for hyperglycaemia, ongoing losses, heart or renal failure and concurrent desmopressin. Do not use glucose 5% for initial shock resuscitation, and do not deliver a whole estimated deficit without repeat sodium and respiratory reassessment.
Open full textbook →Answer 2 questions
Sources and review status5 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • Society for Endocrinology AVP deficiency guidanceCurrent inpatient risk categories, sodium monitoring and fluid-versus-desmopressin priorities.
  • NHS England desmopressin safety alertNational safety warning on fatal dehydration and hypernatraemia after omitted or delayed treatment.
  • NICE CG174 adult intravenous fluidsResuscitation, replacement, maintenance and repeated assessment principles.
  • Desmopressin injection SmPCLicensed central AVP-deficiency indication, routes, individual dosing and safety details.
  • BNF fluids and electrolytes summaryUK formulary context for enteral and intravenous water and electrolyte replacement.

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom